Lanean...
Considerations in the development of generic disease therapies for multiple sclerosis
PURPOSE OF REVIEW: Medication prices are a major contributor to the high cost of care for multiple sclerosis (MS). The patents for some of the initial injectable therapies for relapsing MS recently expired, permitting development, regulatory approval, and marketing of generic alternatives with the p...
Gorde:
| Argitaratua izan da: | Neurol Clin Pract |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Lippincott Williams & Wilkins
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4987120/ https://ncbi.nlm.nih.gov/pubmed/27574572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000267 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|